Security National Bank Increases Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Security National Bank increased its holdings in Zoetis Inc. (NYSE:ZTS) by 1.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 47,467 shares of the company’s stock after buying an additional 609 shares during the period. Zoetis comprises about 1.2% of Security National Bank’s holdings, making the stock its 19th largest position. Security National Bank’s holdings in Zoetis were worth $8,032,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Hohimer Wealth Management LLC raised its position in shares of Zoetis by 1.2% during the fourth quarter. Hohimer Wealth Management LLC now owns 4,386 shares of the company’s stock worth $866,000 after purchasing an additional 52 shares during the period. Forum Financial Management LP lifted its stake in Zoetis by 0.8% in the fourth quarter. Forum Financial Management LP now owns 7,386 shares of the company’s stock valued at $1,458,000 after buying an additional 56 shares in the last quarter. Angeles Wealth Management LLC boosted its holdings in shares of Zoetis by 3.5% in the fourth quarter. Angeles Wealth Management LLC now owns 1,640 shares of the company’s stock valued at $324,000 after buying an additional 56 shares during the period. Prossimo Advisors LLC boosted its holdings in shares of Zoetis by 1.7% in the fourth quarter. Prossimo Advisors LLC now owns 3,498 shares of the company’s stock valued at $690,000 after buying an additional 57 shares during the period. Finally, River Street Advisors LLC increased its position in shares of Zoetis by 3.4% during the fourth quarter. River Street Advisors LLC now owns 1,757 shares of the company’s stock worth $347,000 after acquiring an additional 58 shares in the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on ZTS. Barclays decreased their price target on shares of Zoetis from $260.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 23rd. Piper Sandler reiterated an “overweight” rating and issued a $195.00 target price (down from $220.00) on shares of Zoetis in a research note on Tuesday, April 16th. HSBC dropped their price target on Zoetis from $230.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. Stifel Nicolaus lowered their price objective on Zoetis from $195.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. Finally, The Goldman Sachs Group decreased their price target on shares of Zoetis from $223.00 to $196.00 and set a “buy” rating on the stock in a research note on Monday, May 6th. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $211.75.

Zoetis Stock Up 1.9 %

NYSE ZTS traded up $3.11 on Wednesday, hitting $171.09. 1,327,929 shares of the company were exchanged, compared to its average volume of 2,944,039. The stock has a fifty day moving average of $167.30 and a 200-day moving average of $179.00. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The company has a market cap of $78.07 billion, a PE ratio of 32.47, a PEG ratio of 2.61 and a beta of 0.88. The company has a current ratio of 3.33, a quick ratio of 1.94 and a debt-to-equity ratio of 1.30.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $1.38 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.04. Zoetis had a return on equity of 50.34% and a net margin of 27.38%. The company had revenue of $2.19 billion during the quarter, compared to analyst estimates of $2.14 billion. During the same quarter last year, the firm posted $1.31 EPS. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. As a group, analysts forecast that Zoetis Inc. will post 5.76 earnings per share for the current year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 4th. Investors of record on Thursday, July 18th will be given a $0.432 dividend. This represents a $1.73 annualized dividend and a dividend yield of 1.01%. The ex-dividend date is Thursday, July 18th. Zoetis’s dividend payout ratio (DPR) is 33.33%.

Insider Transactions at Zoetis

In other news, EVP Roxanne Lagano sold 923 shares of Zoetis stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $151.17, for a total value of $139,529.91. Following the transaction, the executive vice president now owns 14,800 shares in the company, valued at $2,237,316. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.16% of the stock is currently owned by insiders.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.